Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia

被引：0
|
作者：
Ajina, R. [1 ]
Alhareeri, A. [1 ]
Philip, W. [1 ]
Alsekait, N. [2 ]
Alarifi, N. [2 ]
Alismail, H. [1 ]
Alshieban, S. [3 ]
Almuzzaini, B. [4 ]
Alshammari, K. [5 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[4] KSAU HS, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[5] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-288
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status
    Li, Yingjie
    Tan, Luxin
    Chen, Nan
    Liu, Xinzhi
    Liang, Fei
    Yao, Yunfeng
    Zhang, Xiaoyan
    Wu, Aiwen
    DISEASES OF THE COLON & RECTUM, 2024, 67 (11) : 1413 - 1422
  • [42] Real-world prevalence of MSI-H/dMMR across 6 different tumor types in Asia
    Tan, D. S.
    Kim, Y. M.
    Lim, M-C.
    Sho, M.
    Lu, C-H.
    Nagao, S.
    Kubo, S.
    Kim, B-G.
    Chen, L-T.
    Kanai, M.
    Wang, P-H.
    Rha, S. Y.
    Ramar, R.
    Wong, M. T.
    Sasaki, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S585 - S585
  • [43] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [44] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [45] Real-world (RW) treatment patterns and clinical outcomes for chemotherapy-based regimens in first line (1L) MSI-H/dMMR metastatic colorectal cancer (mCRC).
    Chase, Monica
    Amonkar, Mayur
    Myer, Nicole
    Wang, Tongtong
    Turzhitsky, Vladimir
    Spira, Alexander I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18755 - E18755
  • [46] Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
    Zhou, Chengjing
    Jiang, Ting
    Li, Rongzhen
    Yuan, Yan
    Xie, Weihao
    Huang, Xiaoxue
    Wang, Qiaoxuan
    Chang, Hui
    Chen, Gong
    Li, Yuhong
    Zeng, Zhifan
    Xiao, Weiwei
    Gao, Yuanhong
    CANCER COMMUNICATIONS, 2021, 41 (09) : 921 - 924
  • [47] Real-world (RW) biomarker characteristics and clinical outcomes in pretreated non-MSI-H/dMMR metastatic colorectal cancer (mCRC) patients
    Amonkar, Mayur M.
    Sura, Sneha
    Desai, Kaushal
    Jain, Rishi
    Liu, Zhimei
    Niehoff, Nicole
    Wilson, Thomas W.
    Patton, Gregory
    Cosgrove, David
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Prognostic role of systemic inflammatory markers in patients with metastatic MSI-h/dMMR colorectal cancer receiving immunotherapy.
    Bhamidipati, Deepak
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Kopetz, Scott
    Kee, Bryan K.
    Johnson, Benny
    Willis, Jason
    Dasari, Arvind
    Morelli, Maria Pia
    Parseghian, Christine Megerdichian
    Lee, Michael Sangmin
    Le, Phat
    Shen, John Paul Y. C.
    Ludford, Kaysia
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Clinical outcomes of immune checkpoint inhibitor (ICI) therapy among Veterans Affairs patients with colorectal cancer and discordant dMMR/MSI-H status.
    Isaacs, James
    Guo, Aixia
    Vashistha, Vishal
    Katsoulakis, Evangelia
    Boswell, Elizabeth
    Strickler, John H.
    Ahmed, Sara
    Kelley, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian center
    Ng, Kennedy
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Tan, Sze Huey
    Ang, Andrea Jing Shi
    Lee, Joycelyn Jie Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345